MyAverix Finance
F · Healthcare
EGETIS THERAPEUTICS AB (P0F)
Biotechnology
EGETIS THERAPEUTICS AB (P0F) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $195.01M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for P0F
EGETIS THERAPEUTICS AB (P0F) — FAQ
What is EGETIS THERAPEUTICS AB's market cap?
EGETIS THERAPEUTICS AB (P0F) has a reported market cap of $195.01M (data as of 2026-03-30).
What is P0F's P/E ratio?
The price-to-earnings (P/E) ratio for EGETIS THERAPEUTICS AB (P0F) is 18.00 (data as of 2026-03-30).
Does EGETIS THERAPEUTICS AB pay a dividend?
Dividend yield is not available in the current snapshot for EGETIS THERAPEUTICS AB (P0F). Check the MyAverix Finance app for the latest dividend data.
What sector is EGETIS THERAPEUTICS AB in?
EGETIS THERAPEUTICS AB (P0F) is classified in the Healthcare sector (Biotechnology industry).
What exchange is P0F listed on?
P0F is listed on F.
What is EGETIS THERAPEUTICS AB's net margin?
EGETIS THERAPEUTICS AB (P0F) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.